Conference Coverage

Scalp Cooling Protects Against Chemotherapy-Induced Alopecia

Publish date: July 5, 2012

 

AT THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY

The trial was funded by the Fondations des Hôpitaux Enfant-Jésus et Saint-Sacrement, the Canadian Breast Cancer Research Alliance, and Sanofi-Aventis. Dr. Lemieux received a research grant from the Fonds de la Recherche en Santé du Québec.

Pages

Recommended Reading

DCIS Score Independently Predicts Ipsilateral Breast Events
MDedge Hematology and Oncology
Radiation Therapy Beneficial Even for 'Good-Risk' Ductal Carcinoma
MDedge Hematology and Oncology
Neoadjuvant Lapatinib Fails to Surpass Trastuzumab in HER2+ Breast Cancer
MDedge Hematology and Oncology
Vitamin D Eases Aromatase Inhibitor-Related Arthralgia
MDedge Hematology and Oncology
FDA Panel Backs MarginProbe Breast Cancer Detection Device
MDedge Hematology and Oncology
EMA Recommends Everolimus for Breast Cancer
MDedge Hematology and Oncology
Chemotherapy-induced nausea and vomiting in Asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy
MDedge Hematology and Oncology
NICE Rejects Bevacizumab Plus Capecitabine for Breast Cancer
MDedge Hematology and Oncology
Balancing the efficacy and safety of ixabepilone: optimizing treatment in metastatic breast cancer
MDedge Hematology and Oncology
Intrathecal trastuzumab: 46 months and no progression
MDedge Hematology and Oncology